πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,432 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9029550

Conformationally restricted urea inhibitors of soluble epoxide hydrolase

The Regents of the University of California Β· Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9029546

Pyrazolopyridine kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9029344

Linked purine pterin HPPK inhibitors useful as antibacterial agents

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9023340

Wnt inhibitors for human stem cell differentiation

ChemRegen, Inc. Β· Granted Tue May 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9023858

Substituted pyrido[2,3-d]pyrimidines as delta-5-desaturase inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue May 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9023356

Treatment method using EGFR antibodies and SRC inhibitors and related formulations

The Regents of the University of California Β· Granted Tue May 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9018201

Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in trea

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8999982

Pharmaceutically active compounds as Axl inhibitors

Lead Discovery Center GmbH Β· Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9000191

Serotonin reuptake inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9000179

Inhibitors of proliferation and activation of signal transducer and activator of transcrip

The Board of Regents of the University of Texas System Β· Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9000025

Autotaxin inhibitors and uses thereof

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8999988

Protein kinase inhibitors

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8999987

Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8999934

Treatment of astrocytes-tumor cells inhibitors of endothelin receptors

The Board of Regents of the University of Texas System Β· Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8993752

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8993585

Cyclic amine substituted pyrimidinediamines as PKC inhibitors

Rigel Pharmaceuticals, Inc. Β· Granted Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8987294

Small molecule inhibitors of the Ξ±4-paxillin interaction

The Regents of the University of California Β· Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8987454

Azaindoles useful as inhibitors of JAK and other protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8980902

Poly (ADP-ribose) polymerase (PARP) inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8980838

Cyclized peptidomimetic small molecule inhibitors of the WDR5 and MLL1 interaction

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8969359

Gyrase and topoisomerase IV inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8969360

Compounds useful as inhibitors of ATR kinase

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8969356

Compounds useful as inhibitors of ATR kinase

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8962631

Compounds useful as inhibitors of ATR kinase

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted